Articles by Jill Wechsler - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jill Wechsler
« Previous
123456789101112
Next »

Meningitis Outbreak Linked to Contaminated Vials of Steroid Injectables

Oct 9, 2012
By: Jill Wechsler

A national fungal meningitis outbreak linked to contaminated vials of steroid injectables from a Massachusetts compounding operation has reignited the debate over the safety of compounded drugs and the need for stronger FDA regulation of these activities. Last week, the Centers for Disease Control and Prevention reported seven deaths and 91 ill.

New Era for Generic Drugs

User fees aim to speed approvals and support timely plant inspections.
Oct 2, 2012
By: Jill Wechsler

The promise of the Generic Drug User Fee Amendments of 2012 is to end multiyear reviews of new generic drugs and the ever-growing queue of pending applications.

Campaign Mounts to Curb Counterfeit Drugs

Import controls and risk strategies aim to promote quality and spur new drug development.
Sep 2, 2012
By: Jill Wechsler

Import controls and risk strategies aim to promote quality and spur new drug development.

Healthcare Reform is Given the Go-Ahead: Now What?

No matter the upside or downside to the Affordable Care Act, there's work to be done.
Aug 2, 2012
By: Jill Wechsler

No matter the upside or downside to the Affordable Care Act, there's work to be done.

FDA User-Fee Legislation Sets Stage for Change

Import controls and risk strategies aim to promote quality and spur new drug development.
Aug 2, 2012
By: Jill Wechsler

Import controls and risk strategies aim to promote quality and spur new drug development.

International AIDS Conference Highlights ARV Advances

Jul 31, 2012
By: Jill Wechsler

Prominent scientists and political leaders at the International AIDS Conference in Washington, D.C., in late July were optimistic for the first time about bringing an end to the global AIDS pandemic.

FDA Adopts New Strategies to Oversee Global Economy

A Q&A with FDA Deputy Commissioner Deborah Autor.
Jul 2, 2012
By: Jill Wechsler

A Q&A with FDA Deputy Commissioner Deborah Autor.

Commentary: Healthcare Reform is Ruled Constitutional

Jun 29, 2012
By: Jill Wechsler

In a 5–4 vote, the Supreme Court has ruled in favor of the Constitutionality of the Affordable Care Act.

Congress Move Promptly to Finalize FDA User Fees

Jun 20, 2012
By: Jill Wechsler

Legislation fails to establish national track-and-trace system, but tackles shortages.

« Previous
123456789101112
Next »

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
13%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here